We are live on ! Find out more
QTTB icon

Q32 Bio

106 hedge funds and large institutions have $262M invested in Q32 Bio in 2026 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

259% more capital inflows, than outflows

Capital inflows: $181M | Capital outflows: $50.4M

220% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 15

60% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 15

45% more funds holding

Funds holding: 73 → 106 (+33)

0% less call options, than puts

Call options by funds: $585K | Put options by funds: $587K

45.84% less ownership

Funds ownership: 151.68% → 105.84% (-46%)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
106
Holders Change
+33
Holders Change %
+45.21%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
48
Increased
24
Reduced
15
Closed
15
Calls
$585​K
Puts
$587​K
Net Calls
-⁠$2​K
Net Calls Change
+$3.33​M

QTTB Hedge Fund Activity: Q3 2026 in Review

106 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2026, worth a combined $262M — down 7.3% from $283M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new QTTB positions and 15 closed out — a net gain of 33 holders — while 24 added to existing stakes and 15 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $30.5M. The largest seller was Point72 Asset Management, cutting an estimated $11.5M.

  • 106 institutional investors held Q32 Bio (QTTB) as of Q3 2026, up from 73 in Q2 2026.
  • Funds reported $262M of Q32 Bio stock for Q3 2026, down 7.3% quarter-over-quarter.
  • 48 funds opened new Q32 Bio positions in Q3 2026 and 15 closed out, a net change of +33 holders.
  • The largest Q32 Bio buyer in Q3 2026 was Bank of America, an estimated $30.5M added.
  • The largest Q32 Bio seller in Q3 2026 was Point72 Asset Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2026.